Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes

Nature Medicine

Volumn 12, Issue 5, 2006, Pages 557-567

  Jin, David K ^a   Shido, Koji ^a   Kopp, Hans Georg ^a   Petit, Isabelle ^a   Shmelkov, Sergey V ^a   Young, Lauren M ^a   Hooper, Andrea T ^a   Amano, Hideki ^a   Avecilla, Scott T ^a   Heissig, Beate ^a   Hattori, Koichi ^a   Zhang, Fan ^a   Hicklin, Daniel J ^b   Wu, Yan ^b   Zhu, Zhenping ^b   Dunn, Ashley ^c   Salari, Hassan ^d   Werb, Zena ^e   Hackett, Neil R ^a   Crystal, Ronald G ^a   Lyden, David ^a   Rafii, Shahin ^a   more..

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d Chemokine Therapeutics Corporation   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; ERYTHROPOIETIN; GELATINASE B; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; THROMBOPOIETIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HEMANGIOCYTE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LIMB ISCHEMIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; REVASCULARIZATION; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA; VASCULAR DISEASE;

ANIMALS; BLOOD PLATELETS; CHEMOKINES, CXC; CYTOKINES; HUMANS; ISCHEMIA; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, CXCR4; REGENERATION; STEM CELL FACTOR; STEM CELLS; THROMBOCYTOPENIA; THROMBOPOIETIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

ANIMALIA;

EID: 33646581046     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1400     Document Type: Article

References (50)

1. Rafii, S. & Lyden, D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9, 702-712 (2003).
2. Coussens, L.M. & Werb, Z. Inflammation and cancer. Nature 420, 860-867 (2002).
3. Coussens, L.M., Tinkle, C.L., Hanahan, D. & Werb, Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103, 481-490 (2000).
4. Takakura, N. et al. A role for hematopoietic stem cells in promoting angiogenesis. Cell 102, 199-209 (2000).
5. Aicher, A. et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med. 9, 1370-1376 (2003).
6. Luttun, A. et al. Revascularization of ischemic tissues by PIGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med. 8, 831-840 (2002).
7. Cursiefen, C. et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113, 1040-1050 (2004).
8. Yang, L. et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 6, 409-421 (2004).
9. Lyden, D. et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7, 1194-1201 (2001).
10. Conejo-Garcia, J.R. et al. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 10, 950-958 (2004).
11. De Palma, M. et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8, 211-226 (2005).
12. Takahashi, T. et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5, 434-438 (1999).
13. Heeschen, C. et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102, 1340-1346 (2003).
14. Kertesz, N., Wu, J., Chen, T.H., Sucov, H.M. & Wu, H. The role of erythropoietin in regulating angiogenesis. Dev. Biol. 276, 101-110 (2004).
15. Henke, M. et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 362, 1255-1260 (2003).
16. Matsui, J., Wakabayashi, T., Asada, M., Yoshimatsu, K. & Okada, M. Stem cell factor/c-kit signaling promotes the survival, migration, and capillary tube formation of human umbilical vein endothelial cells. J. Biol. Chem. 279, 18600-18607 (2004).
17. Brizzi, M.F. et al. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. Circ. Res. 84, 785-796 (1999).
18. Zou, Y.R., Kottmann, A.H., Kuroda, M., Taniuchi, I. & Littman, D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595-599 (1998).
19. Avecilla, S.T. et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat. Med. 10, 64-71 (2004).
20. Petit, I. et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat. Immunol. 3, 687-694 (2002).
21. Butler, J.M. et al. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J. Clin. Invest. 115, 86-93 (2005).
22. Walter, D.H. et al. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ. Res. 97, 1142-1151 (2005).
23. Ceradini, D.J. et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, 858-864 (2004).
24. De Falco, E. et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104, 3472-3482 (2004).
25. Kaplan, R.N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820-827 (2005).
26. Hattori, K. et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat. Med. 8, 841-849 (2002).
27. Bunting, S. et al. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. Blood 90, 3423-3429 (1997).
28. Gurney, A.L., Carver-Moore, K., de Sauvage, F.J. & Moore, M.W. Thrombocytopenia in c-mpl-deficient mice. Science 265, 1445-1447 (1994).
29. Basu, S. et al. "Emergency" granulopoiesis in G-CSF-deficient mice in response to Candida albicans infection. Blood 95, 3725-3733 (2000).
30. Heissig, B. et al. Recruitment of stem and progenitor cells from the bone marrow niche requires mmp-9 mediated release of kit-ligand. Cell 109, 625-637 (2002).
31. Johnson, C., Sung, H.J., Lessner, S.M., Fini, M.E. & Galis, Z.S. Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching. Circ. Res. 94, 262-268 (2004).
32. Forster, R. et al. Intracellular and surface expression of the HIV-1 coreceptor CXCR4/ fusin on various leukocyte subsets: rapid internalization and recycling upon activation. J. Immunol. 160, 1522-1531 (1998).
33. Crump, M.P. et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16, 6996-7007 (1997).
34. Perez, L.E. et al. Increased plasma levels of stromal-derived factor-1 (SDF-1/CXCL12) enhance human thrombopoiesis and mobilize human colony-forming cells (CFC) in NOD/SCID mice. Exp. Hematol. 32, 300-307 (2004).
35. Dar, A. et al. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat. Immunol. 6, 1038-1046 (2005).
36. Mohle, R., Green, D., Moore, M.A., Nachman, R.L. & Rafii, S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. USA 94, 663-668 (1997).
37. Li, J.J., Huang, Y.Q., Basch, R. & Karpatkin, S. Thrombin induces the release of angiopoietin-1 from platelets. Thromb. Haemost. 85, 204-206 (2001).
38. Avraham, H. et al. Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells. Blood 79, 365-371 (1992).
39. Kirito, K. & Kaushansky, K. Thrombopoietin stimulates vascular endothelial cell growth factor (VEGF) production in hematopoietic stem cells. Cell Cycle 4, 1729-1731 (2005).
40. Selheim, F., Holmsen, H. & Vassbotn, F.S. Identification of functional VEGF receptors on human platelets. FEBS Lett. 512, 107-110 (2002).
41. Grunewald, M. et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124, 175-189 (2006).
42. Lapidot, T., Dar, A. & Kollet, O. How do stem cells find their way home? Blood 106, 1901-1910 (2005).
43. Papayannopoulou, T. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood 103, 1580-1585 (2004).
44. Hattori, K., Heissig, B. & Rafii, S. The regulation of hematopoietic stem cell and progenitor mobilization by chemokine SDF-1. Leuk. Lymphoma 44, 575-582 (2003).
45. Hattori, K. et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 97, 3354-3360 (2001).
46. Pelus, L.M. et al. The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factor. Exp. Hematol. 33, 295-307 (2005).
47. Broxmeyer, H.E. et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J. Exp. Med. 201, 1307-1318 (2005).
48. Liles, W.C. et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102, 2728-2730 (2003).
49. Losordo, D.W. & Dimmeler, S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 109, 2692-2697 (2004).
50. Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335-348 (2005).